对生殖线TP53 p.K164E乙化位变异的临床和功能分析

Emilia Modolo Pinto1, Enilze M S F Ribeiro2, Jinling Wang3

  • 1Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA; emilia.pinto@stjude.org enilzeribeiro@gmail.com gerard.zambetti@stjude.org.

概括

在早期乳腺癌中发现的TP53 p.K164E变体会损害瘤抑制功能. 这项研究将其重新归类为可能致病性,影响癌症风险评估.